ENG/中
老虎证券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Apimeds Pharmaceutical U.S, Inc.
1.31
+0.0700
5.65%
盘后：
1.28
-0.0300
-2.29%
19:24 EST
成交量：
3.55万
成交额：
4.57万
市值：
1,647.45万
市盈率：
-3.20
高：
1.38
开：
1.18
低：
1.18
收：
1.24
52周最高：
4.03
52周最低：
0.9510
股本：
1,257.60万
流通股本：
337.50万
量比：
0.08
换手率：
1.05%
股息：
- -
股息率：
- -
每股收益(TTM):
-0.4100
每股收益(LYR):
-0.1759
净资产收益率：
-144.99%
总资产收益率：
-69.29%
市净率：
2.02
市盈率(LYR):
-7.45
数据加载中...
总览
公司
新闻资讯
公告
2026/02/18
企业合并公告
Form 425 - Prospectuses and communications, business combinations
2026/02/18
重要事件披露
Form 8-K/A - Current report: [Amend]
2026/01/02
重要事件披露
Form 8-K - Current report
2025/12/10
重要事件披露
Form 8-K - Current report
2025/12/10
重要事件披露
Form 8-K/A - Current report: [Amend]
2025/12/02
企业合并公告
Form 425 - Prospectuses and communications, business combinations
2025/12/02
重要事件披露
Form 8-K - Current report
2025/11/19
重要事件披露
Form 8-K - Current report
2025/11/12
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/16
重要事件披露
Form 8-K - Current report
2025/08/19
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/16
重要事件披露
Form 8-K - Current report
2025/06/05
重要事件披露
Form 8-K - Current report
2025/05/23
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/20
重要事件披露
Form 8-K - Current report
2025/05/20
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12
重要事件披露
Form 8-K - Current report
2025/05/06
SEC问询函
Form CORRESP - Correspondence
2025/05/06
SEC问询函
Form CORRESP - Correspondence
2025/05/02
[修订]年度报告
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/APUS/filings"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical U.S, Inc.","latestPrice":1.31,"timestamp":1771966800000,"preClose":1.24,"halted":0,"volume":35476,"hourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.31,"latestTime":"19:24 EST","volume":750,"amount":937.99005,"timestamp":1771979091205,"change":-0.03,"changeRate":-0.022901,"amplitude":0.068015},"delay":0,"changeRate":0.05645161290322586,"floatShares":3375000,"shares":12575983,"eps":-0.41,"marketStatus":"盘后交易","change":0.07,"latestTime":"02-24 19:49:03 EST","open":1.18,"high":1.3786,"low":1.18,"amount":45694.4396356,"amplitude":0.160161,"askPrice":1.6,"askSize":100,"bidPrice":1.22,"bidSize":196,"shortable":0,"etf":0,"ttmEps":-0.41,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":1.24,"preHourTrading":{"tag":"盘前","latestPrice":1.29,"preClose":1.24,"latestTime":"09:04 EST","volume":210,"amount":271.179993,"timestamp":1771941867466,"change":0.05,"changeRate":0.040323,"amplitude":0.001129},"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.31,"latestTime":"19:24 EST","volume":750,"amount":937.99005,"timestamp":1771979091205,"change":-0.03,"changeRate":-0.022901,"amplitude":0.068015},"volumeRatio":0.076022},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":3375000,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":0.076022,"shares":12575983,"dividePrice":0,"high":1.3786,"amplitude":0.160161,"preClose":1.24,"low":1.18,"week52Low":0.951,"pbRate":"2.02","week52High":4.031,"institutionHeld":0,"latestPrice":1.31,"committee":0.324324,"eps":-0.41,"divideRate":0,"volume":35476,"delay":0,"ttmEps":-0.41,"open":1.18,"prevYearClose":1.64,"prevWeekClose":1.3897,"prevMonthClose":1.85,"prevQuarterClose":1.64,"fiveDayClose":1.15,"twentyDayClose":1.6,"sixtyDayClose":1.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-3.02439,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1771939249401},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"APUS\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"20744148","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026017331-APUS","pdf_url":"","pub_time":1771363918000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"APUS","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"企业合并公告","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-017331-index.html","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 2 TO FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017331/ea0277267-8ka2_api.htm","primary":true,"translateUrl":"","linkName":"ea0277267-8ka2_api.htm","type":"425","id":"NTFILEDi2Wnf8XB59PFJPU","market":"us","size":28296},{"description":"UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2025, AND FOR TH","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017331/ea027726701ex99-1_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-1_api.htm","type":"EX-99.1","id":"NTFILEGGFK5SaXjmzoh31z","market":"us","size":164577},{"description":"AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED MARCH 31, 2025 AND","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017331/ea027726701ex99-2_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-2_api.htm","type":"EX-99.2","id":"NTFILEFyb6eeG14Q9xtfUZ","market":"us","size":167378},{"description":"UNAUDITED PROFORMA CONSOLIDATED FINANCIAL INFORMATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017331/ea027726701ex99-3_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-3_api.htm","type":"EX-99.3","id":"NTFILEBJWTu76qbJHpkoPG","market":"us","size":94139}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"企业合并公告","pubTime":"2026-02-18 05:31","pubTimestamp":1771363918,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20744182","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026017323-APUS","pdf_url":"","pub_time":1771363828000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"APUS","title":"Form 8-K/A - Current report: [Amend]","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-017323-index.html","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 2 TO FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea0277267-8ka2_api.htm","primary":true,"translateUrl":"","linkName":"ea0277267-8ka2_api.htm","type":"8-K/A","id":"NTFILE9BYLZYNBr4hUb6TN","market":"us","size":33151},{"description":"UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2025, AND FOR TH","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea027726701ex99-1_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-1_api.htm","type":"EX-99.1","id":"NTFILEEmjEcULRxUu9Nu7m","market":"us","size":164577},{"description":"AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED MARCH 31, 2025 AND","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea027726701ex99-2_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-2_api.htm","type":"EX-99.2","id":"NTFILEH9NPma2AZzkzwiy3","market":"us","size":167378},{"description":"UNAUDITED PROFORMA CONSOLIDATED FINANCIAL INFORMATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea027726701ex99-3_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-3_api.htm","type":"EX-99.3","id":"NTFILEHXNc7TeMG7VdL6fZ","market":"us","size":94139}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-18 05:30","pubTimestamp":1771363828,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20594368","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026000464-APUS","pdf_url":"","pub_time":1767330000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026000464/0001213900-26-000464-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026000464/ea0271636-8k_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0271636-8k_apimeds.htm","type":"8-K","id":"NTFILEHY4Xbr2NsH1Jo9Zk","market":"us","size":26870}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-02 13:00","pubTimestamp":1767330000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20514403","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025119894-APUS","pdf_url":"","pub_time":1765342800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/0001213900-25-119894-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/ea0268648-8k_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0268648-8k_apimeds.htm","type":"8-K","id":"NTFILE4bxxAno9wVTcRunj","market":"us","size":22019}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-10 13:00","pubTimestamp":1765342800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20514397","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025119893-APUS","pdf_url":"","pub_time":1765342800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"APUS","title":"Form 8-K/A - Current report: [Amend]","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/0001213900-25-119893-index.htm","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/ea0268649-8ka1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0268649-8ka1_apimeds.htm","type":"8-K/A","id":"NTFILEFuFeXBnC8h39uVrT","market":"us","size":38321},{"description":"AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHA","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/ea026864901ex2-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026864901ex2-1_apimeds.htm","type":"EX-2.1","id":"NTFILE4DaVBPD6pyvqh8fJ","market":"us","size":470719},{"description":"CERTIFICATE OF CORRECTION TO CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/ea026864901ex3-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026864901ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILE7G4TCSXWLCMcUXtR","market":"us","size":7834},{"description":"AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT DATED DECEMBER 8, 2025 BY AND B","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/ea026864901ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026864901ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILE8S5QTaUYdVbXHXuQ","market":"us","size":22402}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-10 13:00","pubTimestamp":1765342800,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20479272","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025117176-APUS","pdf_url":"","pub_time":1764651600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"APUS","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"企业合并公告","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/0001213900-25-117176-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea0267807-8k425_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0267807-8k425_apimeds.htm","type":"425","id":"NTFILE9rQhvKYqYcAn6HNq","market":"us","size":99345},{"description":"AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHA","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex2-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex2-1_apimeds.htm","type":"EX-2.1","id":"NTFILEAemMZkjRsuzW2XWn","market":"us","size":467002},{"description":"CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK, AS FILED WIT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex3-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILEHFCxmwtv6dqY4VDu","market":"us","size":33204},{"description":"FORM OF NOTE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEH4MBk71gu2mRYMQ9","market":"us","size":254303},{"description":"WARRANT ISSUED TO E.F. HUTTON & CO. LLC, DATED DECEMBER 1, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex4-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-2_apimeds.htm","type":"EX-4.2","id":"NTFILE53LnuA1NnbVYp26s","market":"us","size":114309},{"description":"ACQUIROR SUPPORT AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHARM","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILE87exrBV9W1UYxvTW","market":"us","size":76051},{"description":"SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PH","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILEAMUxGpUpesyggLMB","market":"us","size":355963},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILE37ecYDuxBcWe5oBa","market":"us","size":172450},{"description":"FORM OF VOTING AGREEMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-4_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-4_apimeds.htm","type":"EX-10.4","id":"NTFILEHQJ3r6NdRBDs4B4D","market":"us","size":28610},{"description":"PRESS RELEASE, DATED DECEMBER 1, 2025","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILEGBTvjSG1PhuF2rCF","market":"us","size":22873}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"企业合并公告","pubTime":"2025-12-02 13:00","pubTimestamp":1764651600,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20479258","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025117173-APUS","pdf_url":"","pub_time":1764651600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/0001213900-25-117173-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex2-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026780701ex2-1_apimeds.htm","type":"EX-2.1","id":"NTFILEEG389FrDe8dzf4kg","market":"us","size":467002},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea0267807-8k425_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0267807-8k425_apimeds.htm","type":"8-K","id":"NTFILE3noYJLNUrgWgnwyZ","market":"us","size":107188},{"description":"CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK, AS FILED WIT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex3-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILE6QXWFUMqW29aPJB9","market":"us","size":33204},{"description":"FORM OF NOTE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEEqKU5UR8S9U8BqGG","market":"us","size":254303},{"description":"WARRANT ISSUED TO E.F. HUTTON & CO. LLC, DATED DECEMBER 1, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex4-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-2_apimeds.htm","type":"EX-4.2","id":"NTFILEDWaWK18dhobHfwWp","market":"us","size":114309},{"description":"ACQUIROR SUPPORT AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHARM","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEEPSkr1v9J7eKNWoz","market":"us","size":76051},{"description":"SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PH","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILEGdKXYKyyZ4WQ3tDa","market":"us","size":355963},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILE9EHk7mEQnWVZqiHQ","market":"us","size":172450},{"description":"FORM OF VOTING AGREEMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-4_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-4_apimeds.htm","type":"EX-10.4","id":"NTFILE5wqMf8ndaqGUKhke","market":"us","size":28610},{"description":"PRESS RELEASE, DATED DECEMBER 1, 2025","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILE85coqPEBeDXKCWTt","market":"us","size":22873}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-02 13:00","pubTimestamp":1764651600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第2.01项：资产收购或处置完成；第2.03项：设立直接财务义务或注册人资产负债表外安排下的义务；第3.02项：未经登记的股本证券销售；第5.01项：注册人控制权的变更；第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；第5.03项：公司章程或章程的修订；财政年度的变化；第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20426913","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025112184-APUS","pdf_url":"","pub_time":1763503060000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-112184-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT, DATED NOVEMBER 13, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025112184/ea026616601ex10-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026616601ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEGawRTNKw4kvbaYcC","market":"us","size":10061},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025112184/ea0266166-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0266166-8k_apimeds.htm","type":"8-K","id":"NTFILEDfr1WG9zawSJPh81","market":"us","size":24427}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-19 05:57","pubTimestamp":1763503060,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20400506","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025109280-APUS","pdf_url":"","pub_time":1762923600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/0001213900-25-109280-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea0264386-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0264386-10q_apimeds.htm","type":"10-Q","id":"NTFILEHyqe94raUy3Fo4nY","market":"us","size":576092},{"description":"WARRANT ISSUED TO MURDOCK CAPITAL PARTNERS CORP., DATED AUGUST 5, 2025","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEB9qZxrxBsEfqCwUX","market":"us","size":63202},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILEDgi8v28Pu5EBXnn4","market":"us","size":15933},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILEHoju1QdxYFKxjXTD","market":"us","size":10335},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILE62f9Ly5MMJmENwKq","market":"us","size":3473},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILE6NrMmj5jZN9ZfCk7","market":"us","size":3619}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-12 13:00","pubTimestamp":1762923600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20273049","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025099553-APUS","pdf_url":"","pub_time":1760587200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/0001213900-25-099553-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FIRST AMENDMENT TO BYLAWS DATED OCTOBER 15, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea026154301ex3-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026154301ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILEjwRyGFcMT7FBfCmZ","market":"us","size":2276},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea0261543-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0261543-8k_apimeds.htm","type":"8-K","id":"NTFILEFjqKdffHFirbA9gJ","market":"us","size":23620}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-10-16 12:00","pubTimestamp":1760587200,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.03项：公司章程或章程的修订；财政年度的变化；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20010168","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025078507-APUS","pdf_url":"","pub_time":1755576000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/0001213900-25-078507-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea0251232-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0251232-10q_apimeds.htm","type":"10-Q","id":"NTFILE2XrgMFFKD7rRNHHL","market":"us","size":547565},{"description":"AMENDMENT TO MAY 2024 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS US,","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILE9cJyFDVkP5trf7gP","market":"us","size":5457},{"description":"AMENDMENT TO AUGUST 2024 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILE72chVnRndzh9Zb7k","market":"us","size":6143},{"description":"AMENDMENT TO MARCH 2025 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS U","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILEAc9Lfp16GVtTq5Y9","market":"us","size":6120},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE7DCEq8fcBhh8gJgP","market":"us","size":9313},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE2vD74iKgKvB1MTTo","market":"us","size":9315},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILEH5X43EKFuZoiruKx","market":"us","size":3231},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILECY2mG11YmP9kowKU","market":"us","size":3241}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-19 12:00","pubTimestamp":1755576000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19882994","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025064446-APUS","pdf_url":"","pub_time":1752638400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/0001213900-25-064446-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE DATED JULY 15, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/ea024916001ex99-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024916001ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILEmN3fT5MbimsCQjYQ","market":"us","size":12075},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/ea0249160-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0249160-8k_apimeds.htm","type":"8-K","id":"NTFILE3bvxq9nAhmqS5h4s","market":"us","size":26453}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-16 12:00","pubTimestamp":1752638400,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19739711","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025051567-APUS","pdf_url":"","pub_time":1749096000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025051567/0001213900-25-051567-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025051567/ea024484201-8k_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024484201-8k_apimeds.htm","type":"8-K","id":"NTFILE8odsqxzEQdrP2LhW","market":"us","size":25286}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-05 12:00","pubTimestamp":1749096000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19690639","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025047373-APUS","pdf_url":"","pub_time":1747972800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"APUS","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/0001213900-25-047373-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea0242959-s8_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0242959-s8_apimeds.htm","type":"S-8","id":"NTFILE52LggoZe9FSSHnne","market":"us","size":53045},{"description":"OPINION OF NELSON MULLINS RILEY & SCARBOROUGH LLP AS TO THE LEGALITY OF THE SECU","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex5-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex5-1_apimeds.htm","type":"EX-5.1","id":"NTFILEGbtC3PY5TFp9DAnt","market":"us","size":12212},{"description":"CONSENT OF KREIT & CHIU CPA LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex23-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex23-1_apimeds.htm","type":"EX-23.1","id":"NTFILEASjHarz4gRW42xs2","market":"us","size":2030},{"description":"FILING FEE TABLE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex-fee_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex-fee_apimeds.htm","type":"EX-FILING FEES","id":"NTFILE6zTmXzxE3Fdy9iq7","market":"us","size":10134},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE4FaMqqBxBSTTBAuz","market":"us","size":2814}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2025-05-23 12:00","pubTimestamp":1747972800,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19671159","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025045643-APUS","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/0001213900-25-045643-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM OF AMENDMENT TO PROMISSORY NOTE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701ex10-1_apimed.htm","primary":true,"translateUrl":"","linkName":"ea024276701ex10-1_apimed.htm","type":"EX-10.1","id":"NTFILEGXcXLPzK3PfgAAB9","market":"us","size":5177},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701-8k_apimed.htm","primary":false,"translateUrl":"","linkName":"ea024276701-8k_apimed.htm","type":"8-K","id":"NTFILECf2xaduGGxzYw5xW","market":"us","size":25001}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19671158","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025045588-APUS","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/0001213900-25-045588-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea0241519-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0241519-10q_apimeds.htm","type":"10-Q","id":"NTFILEEEU2rwaciswP2wSB","market":"us","size":354005},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE6vfDEW92ghBCzDGe","market":"us","size":10274},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE5P147gtvb7K1qznN","market":"us","size":10279},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILE4kZhUNEJuEFWosf4","market":"us","size":3789},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILE5FFDFRBmgG3oeLoF","market":"us","size":3801}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19631585","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025042122-APUS","pdf_url":"","pub_time":1747022400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/0001213900-25-042122-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED MAY 8, 2025, BETWEEN THE COMPANY AND D. BORAL CAPI","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex1-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024171101ex1-1_apimeds.htm","type":"EX-1.1","id":"NTFILEEuWUTJ5frmpR5i91","market":"us","size":471273},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea0241711-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0241711-8k_apimeds.htm","type":"8-K","id":"NTFILE3PRgPNmrXnQw9kdc","market":"us","size":28114},{"description":"REPRESENTATIVE'S WARRANTS, DATED MAY 12, 2025, TO JOSEPH T. RALLO","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILED2mbjCPZrUmANpp2","market":"us","size":118449},{"description":"FORM OF INDEMNIFICATION AGREEMENT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEBJGf68uce4xmdQah","market":"us","size":99414},{"description":"PRESS RELEASE, DATED MAY 8, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILE93jEdW79RkCDHFR4","market":"us","size":13261},{"description":"PRESS RELEASE, DATED MAY 12, 2025","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex99-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex99-2_apimeds.htm","type":"EX-99.2","id":"NTFILEDjSHWbmn3WfmsWgi","market":"us","size":10936}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-12 12:00","pubTimestamp":1747022400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19928808","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025039670-APUS","pdf_url":"","pub_time":1746474573000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-039670-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025039670/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE88uf2DtjWMwsCasn","market":"us","size":5769}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-05-06 03:49","pubTimestamp":1746474573,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19928885","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025039664-APUS","pdf_url":"","pub_time":1746474474000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-039664-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025039664/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8Qg1ZfdBwPitc8qR","market":"us","size":6205}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-05-06 03:47","pubTimestamp":1746474474,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19594720","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025038644-APUS","pdf_url":"","pub_time":1746158400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","symbol":"APUS","title":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","titleType":"[修订]年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/0001213900-25-038644-index.htm","us_notice_code":"Form 10-K/A","us_title_en":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM 10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea0240523-10ka1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0240523-10ka1_apimeds.htm","type":"10-K/A","id":"NTFILEDRwCD4wiaJrBbEoc","market":"us","size":72679},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea024052301ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024052301ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE7ckuwFxfaJAQTkKV","market":"us","size":9548},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea024052301ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024052301ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE8XWnmRSrLZE8AKLz","market":"us","size":9560}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[修订]年度报告","pubTime":"2025-05-02 12:00","pubTimestamp":1746158400,"title_zh":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}